2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗

2018-07-04 国外风湿免疫科相关专家小组 J Foot Ankle Res. 2018 Jul 4;

类风湿性关节炎患者足部问题非常普遍,对生活质量造成重大影响。本文主要针对类风湿性关节炎患者足部问题的诊断和治疗提出指导建议,全文共提出41条指导建议,涉及诊治框架,足部护理,诊断,治疗等。

中文标题:

2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗

英文标题:

Multidisciplinary recommendations for diagnosis and treatment of foot problems in people with rheumatoid arthritis.

发布日期:

2018-07-04

简要介绍:

类风湿性关节炎患者足部问题非常普遍,对生活质量造成重大影响。本文主要针对类风湿性关节炎患者足部问题的诊断和治疗提出指导建议,全文共提出41条指导建议,涉及诊治框架,足部护理,诊断,治疗等。 

拓展指南:类风湿性关节炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=9542f1c001615e3f, title=2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗, enTitle=Multidisciplinary recommendations for diagnosis and treatment of foot problems in people with rheumatoid arthritis., guiderFrom=J Foot Ankle Res. 2018 Jul 4;, authorId=null, author=, summary=类风湿性关节炎患者足部问题非常普遍,对生活质量造成重大影响。本文主要针对类风湿性关节炎患者足部问题的诊断和治疗提出指导建议,全文共提出41条指导建议,涉及诊治框架,足部护理,诊断,治疗等。 , cover=, journalId=null, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jul 04 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>类风湿性关节炎患者足部问题非常普遍,对生活质量造成重大影响。本文主要针对类风湿性关节炎患者足部问题的诊断和治疗提出指导建议,全文共提出41条指导建议,涉及诊治框架,足部护理,诊断,治疗等。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>类风湿性关节炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=cd2cb1c0015a14d5" title="2017 EULAR建议:支持观察研究的核心数据集和类风湿性关节炎的临床护理" target=_blank>2017 EULAR建议:支持观察研究的核心数据集和类风湿性关节炎的临床护理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=057981c00151e549" title="《2017年意大利共识指南:类风湿性关节炎患者HBV感染的管理》摘译" target=_blank>《2017年意大利共识指南:类风湿性关节炎患者HBV感染的管理》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=18ccf1c001a41e99" title="2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理" target=_blank>2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=45a241c001389196" title="2016 EULAR建议:应用合成的和生物类改善病情的抗风湿药物治疗类风湿性关节炎(更新版)" target=_blank>2016 EULAR建议:应用合成的和生物类改善病情的抗风湿药物治疗类风湿性关节炎(更新版)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=f666d1c0013160b4" title="2016 NICE技术评估指南:Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎(TA415)" target=_blank>2016 NICE技术评估指南:Certolizumab pego用于治疗TNFα抑制剂治疗反应不敏感类风湿性关节炎(TA415)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E6%80%A7%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关类风湿性关节炎更多指南</a></ul>, tagList=[TagDto(tagId=2259, tagName=类风湿性关节炎), TagDto(tagId=77911, tagName=足部问题)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6378, appHits=304, showAppHits=0, pcHits=4851, showPcHits=1783, likes=133, shares=4, comments=6, approvalStatus=1, publishedTime=Sun Jul 15 22:27:58 CST 2018, publishedTimeString=2018-07-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 15 22:27:58 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 19:01:40 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗)])
2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=897976, encodeId=7a6789e976d8, content=学习,持续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:21:31 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331928, encodeId=e2c83319286f, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jul 16 07:02:33 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331920, encodeId=cd1c33192030, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 16 07:00:45 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331902, encodeId=ad3833190253, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:26 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331871, encodeId=56133318e156, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jul 16 00:09:50 CST 2018, time=2018-07-16, status=1, ipAttribution=)]
    2020-11-09 Sarah2020cpp

    学习,持续学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=897976, encodeId=7a6789e976d8, content=学习,持续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:21:31 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331928, encodeId=e2c83319286f, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jul 16 07:02:33 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331920, encodeId=cd1c33192030, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 16 07:00:45 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331902, encodeId=ad3833190253, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:26 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331871, encodeId=56133318e156, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jul 16 00:09:50 CST 2018, time=2018-07-16, status=1, ipAttribution=)]
    2018-07-16 龙胆草

    学习谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=897976, encodeId=7a6789e976d8, content=学习,持续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:21:31 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331928, encodeId=e2c83319286f, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jul 16 07:02:33 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331920, encodeId=cd1c33192030, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 16 07:00:45 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331902, encodeId=ad3833190253, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:26 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331871, encodeId=56133318e156, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jul 16 00:09:50 CST 2018, time=2018-07-16, status=1, ipAttribution=)]
    2018-07-16 三生有幸9135

    学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=897976, encodeId=7a6789e976d8, content=学习,持续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:21:31 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331928, encodeId=e2c83319286f, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jul 16 07:02:33 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331920, encodeId=cd1c33192030, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 16 07:00:45 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331902, encodeId=ad3833190253, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:26 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331871, encodeId=56133318e156, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jul 16 00:09:50 CST 2018, time=2018-07-16, status=1, ipAttribution=)]
    2018-07-16 yjs木玉

    学习学习再学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=897976, encodeId=7a6789e976d8, content=学习,持续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0e85433204, createdName=Sarah2020cpp, createdTime=Mon Nov 09 15:21:31 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331928, encodeId=e2c83319286f, content=学习谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4Nd44v3xHnnictn9UpctwtH62EPQ59TMdI9lnqHMgQ16nH7GmGCfpzicsHgjibYVk6vwSpXrC86gMibRkoaIzf5HwSz7/0, createdBy=78cc1691107, createdName=龙胆草, createdTime=Mon Jul 16 07:02:33 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331920, encodeId=cd1c33192030, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Mon Jul 16 07:00:45 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331902, encodeId=ad3833190253, content=学习学习再学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jul 16 06:35:26 CST 2018, time=2018-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=331871, encodeId=56133318e156, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jul 16 00:09:50 CST 2018, time=2018-07-16, status=1, ipAttribution=)]
    2018-07-16 phoebeyan520

    学习了.谢谢分享

    0